Christer Wingren,
Associate Professor And Lecturer,
Lund University
Dr. Wingren is a lecturer at the Dept. of Immunotechnology, Lund University, Sweden. Currently, Dr. Wingren directs a research group working on the development of recombinant antibody microarrays for high-throughput disease proteomics (“unlocking biomarker discovery”), with a particular focus on oncoproteomics and autoimmunity. The research is conducted in a translational manner, going from the bed-to-bench and back again, with the long-term goal to define serum, plasma, and urine biomarkers for disease diagnosis, prognosis, and classification. In 2003, he was promoted to Associate Professor in Immunotechnology. Prior to joining Immunotechnology in 1999, Dr. Wingren pursued his post-doctoral training in structural biology in the laboratory of Prof. Ian Wilson at the Scripps Research Institute, La Jolla, USA (1997-1999). Dr. Wingren received his Ph.D. in biochemistry at Lund University in 1997, and a B.Sc. in chemistry in 1991.
Molecular Profiling of Autoimmune Disease for Improved Diagnosis, Prognosis, and Classification
Tuesday, 17 March 2015 at 16:30
Add to Calendar ▼2015-03-17 16:30:002015-03-17 17:30:00Europe/LondonMolecular Profiling of Autoimmune Disease for Improved Diagnosis, Prognosis, and Classification Microarray Technology in Berlin, GermanyBerlin, GermanySELECTBIOenquiries@selectbiosciences.com
We have shown that affinity proteomics can be used to profile crude, non-fractionated serum and urine proteomes, extracting molecular portraits of SLE and other autoimmune conditions, paving the way for improved (differential) diagnosis, prognosis, and classification based on a blood (urine) test, as well as for an enhanced understanding of the disease biology.
Add to Calendar ▼2015-03-17 00:00:002015-03-18 00:00:00Europe/LondonMicroarray TechnologyMicroarray Technology in Berlin, GermanyBerlin, GermanySELECTBIOenquiries@selectbiosciences.com